We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A Novel Formulation of Glucose-Sparing Peritoneal Dialysis Solutions with l-Carnitine Improves Biocompatibility on Human Mesothelial Cells.
- Authors
Piccapane, Francesca; Bonomini, Mario; Castellano, Giuseppe; Gerbino, Andrea; Carmosino, Monica; Svelto, Maria; Arduini, Arduino; Procino, Giuseppe
- Abstract
The main reason why peritoneal dialysis (PD) still has limited use in the management of patients with end-stage renal disease (ESRD) lies in the fact that the currently used glucose-based PD solutions are not completely biocompatible and determine, over time, the degeneration of the peritoneal membrane (PM) and consequent loss of ultrafiltration (UF). Here we evaluated the biocompatibility of a novel formulation of dialytic solutions, in which a substantial amount of glucose is replaced by two osmometabolic agents, xylitol and l-carnitine. The effect of this novel formulation on cell viability, the integrity of the mesothelial barrier and secretion of pro-inflammatory cytokines was evaluated on human mesothelial cells grown on cell culture inserts and exposed to the PD solution only at the apical side, mimicking the condition of a PD dwell. The results were compared to those obtained after exposure to a panel of dialytic solutions commonly used in clinical practice. We report here compelling evidence that this novel formulation shows better performance in terms of higher cell viability, better preservation of the integrity of the mesothelial layer and reduced release of pro-inflammatory cytokines. This new formulation could represent a step forward towards obtaining PD solutions with high biocompatibility.
- Subjects
PERITONEAL dialysis; CHRONIC kidney failure; BIOCOMPATIBILITY; CELL survival; XYLITOL; CELL culture; DAIRY cattle behavior
- Publication
International Journal of Molecular Sciences, 2021, Vol 22, Issue 1, p123
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms22010123